Influence of Operator Factors on Succes and Survival of Indirect Restorations
Launched by UNIVERSITY MEDICAL CENTER GRONINGEN · Mar 2, 2022
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how different dental practitioners' techniques affect the success and durability of partial indirect restorations, which are tooth repairs made from a strong material called glass ceramics. These restorations are designed to look and function like natural teeth and are applied using a method called immediate dentin sealing (IDS), which helps the bonding process. The researchers want to understand how factors like the use of special tools, the environment during treatment, and the practitioner's experience influence the outcomes of these dental repairs.
To participate in this study, you must be a healthy adult, at least 18 years old, and not have any unstable dental conditions or allergies to the materials used in the restorations. If you join, your dentist will provide information about your treatment, and there will be no additional procedures or risks involved. The researchers will analyze existing dental records and images to check the long-term results of your restoration, such as whether it stays intact and free from decay. This study aims to improve dental care by learning more about how different techniques can lead to better outcomes for patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Healthy individuals
- • Adults
- Exclusion Criteria:
- • Periodontal unstable situation
- • Endodontic unstable situation
- • Allergies for one or more of the used products
About University Medical Center Groningen
University Medical Center Groningen (UMCG) is a leading academic medical center in the Netherlands, renowned for its commitment to innovative research, high-quality patient care, and extensive education in the medical field. As a prominent sponsor of clinical trials, UMCG leverages its multidisciplinary expertise and state-of-the-art facilities to advance medical knowledge and improve therapeutic outcomes. The center fosters collaboration among researchers, healthcare professionals, and industry partners, aiming to translate scientific discoveries into effective treatments that enhance patient health and well-being. With a focus on ethical standards and regulatory compliance, UMCG is dedicated to conducting clinical trials that contribute to the advancement of medicine and the betterment of society.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Groningen, , Netherlands
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials